Legal & General Group’s Myovant Sciences Ltd. MYOV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-33,829
| Closed | -$912K | – | 3407 |
|
|
2022
Q4 | $912K | Sell |
33,829
-520
| -2% | -$14K | ﹤0.01% | 2175 |
|
|
2022
Q3 | $617K | Sell |
34,349
-14,697
| -30% | -$264K | ﹤0.01% | 2292 |
|
|
2022
Q2 | $610K | Buy |
49,046
+20,985
| +75% | +$261K | ﹤0.01% | 2298 |
|
|
2022
Q1 | $373K | Buy |
28,061
+592
| +2% | +$7.87K | ﹤0.01% | 2476 |
|
|
2021
Q4 | $428K | Hold |
27,469
| – | – | ﹤0.01% | 2460 |
|
|
2021
Q3 | $616K | Buy |
27,469
+7,178
| +35% | +$161K | ﹤0.01% | 2367 |
|
|
2021
Q2 | $462K | Hold |
20,291
| – | – | ﹤0.01% | 2351 |
|
|
2021
Q1 | $418K | Buy |
20,291
+19,113
| +1,622% | +$394K | ﹤0.01% | 2327 |
|
|
2020
Q4 | $33K | Sell |
1,178
-1,312
| -53% | -$36.8K | ﹤0.01% | 2922 |
|
|
2020
Q3 | $35K | Hold |
2,490
| – | – | ﹤0.01% | 2802 |
|
|
2020
Q2 | $51K | Hold |
2,490
| – | – | ﹤0.01% | 2724 |
|
|
2020
Q1 | $19K | Hold |
2,490
| – | – | ﹤0.01% | 2934 |
|
|
2019
Q4 | $39K | Buy |
2,490
+1,957
| +367% | +$30.7K | ﹤0.01% | 2925 |
|
|
2019
Q3 | $3K | Hold |
533
| – | – | ﹤0.01% | 3341 |
|
|
2019
Q2 | $5K | Hold |
533
| – | – | ﹤0.01% | 3450 |
|
|
2019
Q1 | $13K | Hold |
533
| – | – | ﹤0.01% | 3212 |
|
|
2018
Q4 | $9K | Buy |
+533
| New | +$9K | ﹤0.01% | 3282 |
|
|
2017
Q2 | – | Sell |
-1,626
| Closed | -$19K | – | 3400 |
|
|
2017
Q1 | $19K | Hold |
1,626
| – | – | ﹤0.01% | 3095 |
|
|
2016
Q4 | $20K | Buy |
+1,626
| New | +$20K | ﹤0.01% | 3117 |
|